tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Kairos Pharma Ltd

KAPA
Add to Watchlist
0.301USD
+0.001+0.37%
Close 07-31 16:00（ET）Quotes delayed by 15 min
6.44MMarket Cap
LossP/E TTM

Kairos Pharma Ltd

0.301
+0.001+0.37%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

KAPA Financials

See Kairos Pharma Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Kairos Pharma Ltd Earnings Date

Latest Release
Jun 5, 2026
EPS / Forecast
-0.08/-0.08
Revenue / Forecast
0.00/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.30
-28.96%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
0.97%-0.08
10.57%-0.07
27.90%-0.07
-319.34%-0.08
-216.06%-0.08
15.91%-0.07
-294.94%-0.10
-7.18%-0.02
-121.20%-0.03
-470.51%-0.09
---0.02
---0.02
---0.01
---0.02
---0.07
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-31.06%-1.65M
-39.29%-1.36M
-33.52%-1.40M
-462.06%-1.42M
-290.71%-1.26M
12.34%-980.00K
-235.58%-1.05M
-7.20%-253.00K
-121.23%-323.00K
-470.41%-1.12M
-33.33%-312.00K
38.70%-236.00K
37.87%-146.00K
---196.00K
---234.00K
---385.00K
---235.00K
Net Margin
---3.31%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-95.60%2.84%
22.87%75.63%
14.75%67.59%
--66.11%
--64.56%
--61.55%
--58.91%
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-27.73%-1.62M
2.14%-1.42M
-256.40%-1.36M
-520.72%-1.38M
-341.11%-1.27M
-32.78%-1.45M
-33.45%-383.00K
-4.72%-222.00K
-127.78%-287.00K
-505.00%-1.09M
-131.45%-287.00K
-76.67%-212.00K
14.29%-126.00K
---180.00K
---124.00K
---120.00K
---147.00K
Net Profit
-31.06%-1.65M
-39.29%-1.36M
-33.52%-1.40M
-462.06%-1.42M
-290.71%-1.26M
12.34%-980.00K
-235.58%-1.05M
-7.20%-253.00K
-121.23%-323.00K
-470.41%-1.12M
-33.33%-312.00K
38.70%-236.00K
37.87%-146.00K
---196.00K
---234.00K
---385.00K
---235.00K
Balance Sheet
Current assets
-26.56%4.44M
29.22%5.39M
40.36%6.66M
12634.21%4.84M
10154.24%6.05M
4027.72%4.17M
3987.93%4.74M
-85.27%38.00K
-84.22%59.00K
--101.00K
--116.00K
--258.00K
--374.00K
----
----
----
----
Total current liabilities
-46.46%431.00K
-79.94%199.00K
-75.96%402.00K
-77.52%676.00K
-70.36%805.00K
-58.75%992.00K
-24.31%1.67M
55.24%3.01M
56.27%2.72M
--2.41M
--2.21M
--1.94M
--1.74M
----
----
----
----
Total assets
-27.63%5.74M
13.38%6.54M
61.19%8.07M
547.86%6.67M
716.56%7.94M
497.72%5.77M
427.85%5.00M
5.32%1.03M
-3.28%972.00K
--965.00K
--948.00K
--978.00K
--1.00M
----
----
----
----
Total liabilities
-46.46%431.00K
-79.94%199.00K
-75.96%402.00K
-81.65%676.00K
-76.13%805.00K
-67.40%992.00K
-40.73%1.67M
45.10%3.68M
44.76%3.37M
--3.04M
--2.82M
--2.54M
--2.33M
----
----
----
----
Total equity
-25.50%5.31M
32.77%6.34M
130.01%7.66M
325.96%6.00M
397.04%7.13M
329.84%4.78M
277.90%3.33M
-70.02%-2.65M
-81.21%-2.40M
---2.08M
---1.87M
---1.56M
---1.32M
----
----
----
----
Cash Flow Statement
Net operating income
-45.10%-1.04M
39.88%-1.08M
58.51%-838.00K
-379.17%-805.00K
-2083.33%-714.00K
-2831.82%-1.80M
-2319.78%-2.02M
-147.06%-168.00K
550.00%36.00K
195.65%66.00K
275.00%91.00K
19.05%-68.00K
94.59%-8.00K
---69.00K
---52.00K
---84.00K
---148.00K
Net financing
-92.81%220.00K
100.00%0.00
-35.22%3.38M
49.66%223.00K
3535.96%3.06M
-97.22%-142.00K
2428.57%5.22M
361.40%149.00K
-23.61%-89.00K
-323.53%-72.00K
-217.28%-224.00K
-118.81%-57.00K
-130.00%-72.00K
---17.00K
--191.00K
--303.00K
--240.00K

FAQs

What are the current assets of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its current assets were 5.39M, with a year-on-year change of 29.22.

What are the total assets of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its total assets of Kairos Pharma Ltd were 6.54M, with a year-on-year change of 13.38.

What are the total liabilities of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its total liabilities of Kairos Pharma Ltd were 199.00K, with a year-on-year change of -79.94.

What is the total equity of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its total equity of Kairos Pharma Ltd was 6.34M, with a year-on-year change of 32.77.

What is the net operating income of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its net operating income of Kairos Pharma Ltd was -5.57M, with a year-on-year change of -137.81.

What is the net financing of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its net financing of Kairos Pharma Ltd was 6.66M, with a year-on-year change of 29.72.

What is the Earnings Per Share (EPS) of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.30, with a year-on-year change of -28.96.

What is the net income of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its net income was -5.45M, with a year-on-year change of -109.26.

What is the Return on Equity (ROE) of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its Return on Equity (ROE) was -97.99, with a year-on-year change of 49.21.

What is the Return on Assets (ROA) of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -88.51, with a year-on-year change of -14.47.

What is the operating profit of Kairos Pharma Ltd?

According to Kairos Pharma Ltd's FY2025 earnings report, its operating profit was -5.57M, with a year-on-year change of -137.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy